Fei-Yun Wu Selected Research

Troleandomycin (TAO)

10/2022	Reduced cortical complexity in patients with thyroid-associated ophthalmopathy.
6/2022	Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging.
1/2022	Altered Long- and Short-Range Functional Connectivity Density in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study.
1/2022	T2 -Weighted MR Imaging-Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid-Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation.
7/2021	Usefulness of readout-segmented EPI-based diffusion tensor imaging of lacrimal gland for detection and disease staging in thyroid-associated ophthalmopathy.
6/2021	Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.
3/2021	Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
2/2021	Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
1/2021	Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.
1/2021	Aberrant brain voxel-wise resting state fMRI in patients with thyroid-associated ophthalmopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei-Yun Wu Research Topics

Disease

15	Graves Ophthalmopathy 10/2022 - 01/2020
7	Ischemic Stroke 12/2022 - 09/2019
5	Stroke (Strokes) 12/2022 - 09/2019
3	Neoplasms (Cancer) 05/2022 - 08/2018
2	Infarction (Infarctions) 12/2022 - 08/2022
2	Papillary Thyroid Cancer 01/2022 - 11/2020
1	Lymphatic Metastasis 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Exophthalmos (Proptosis) 03/2021
1	Optic Nerve Diseases (Optic Neuropathy) 03/2021
1	Cognitive Dysfunction 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Thyroid Neoplasms (Thyroid Cancer) 02/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018
1	Sensorineural Hearing Loss 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2012

Drug/Important Bio-Agent (IBA)

15	Troleandomycin (TAO)FDA Link 10/2022 - 01/2020
4	Cytidine Triphosphate (CTP)IBA 08/2022 - 09/2019
3	IodineIBA 05/2022 - 11/2020
3	GlucocorticoidsIBA 01/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 08/2018 - 01/2018
1	Hematoxylin (Haematoxylon)IBA 12/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2021
1	Contrast MediaIBA 01/2021
1	GadoliniumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012

Therapy/Procedure

4	Therapeutics 06/2021 - 02/2018
3	Thrombectomy 12/2022 - 01/2021
1	Cochlear Implantation 01/2015